Anti-tumour necrosis factor therapy is a risk factor for certain subtypes of chronic rhinosinusitis

被引:0
|
作者
Leonard, C. G.
Masih, C.
McDonald, S.
Taylor, G.
Maiden, N.
Leyden, P. J.
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S148 / S148
页数:1
相关论文
共 50 条
  • [21] Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis
    Maria J Leandro
    Arthritis Research & Therapy, 11
  • [22] Anti-tumour necrosis factor therapy for ulcerative colitis - Evidence to date
    Thukral, Chandrashekhar
    Cheifetz, Adam
    Peppercorn, Mark A.
    DRUGS, 2006, 66 (16) : 2059 - 2065
  • [23] OROFACIAL GRANULOMATOSIS AND ANTI-TUMOUR NECROSIS FACTOR THERAPY: A CASE SERIES
    Elliott, T.
    Nunes, C.
    Campbell, H.
    Poate, T.
    Escudier, M.
    Hirst, J.
    Barnard, K.
    Shaw, P.
    Lomer, M.
    Patel, P.
    Sanderson, J.
    Challacombe, S.
    GUT, 2010, 59 : A97 - A97
  • [24] Anti-tumour necrosis factor therapy for ankylosing spondylitis - unresolved issues
    Jois, R. N.
    Gaffney, K.
    Keat, A.
    RHEUMATOLOGY, 2007, 46 (06) : 899 - 901
  • [25] Anti-tumour necrosis factor therapy ameliorates joint disease in a chronic model of inflammatory arthritis
    Beech, JT
    Thompson, SJ
    BRITISH JOURNAL OF RHEUMATOLOGY, 1997, 36 (10): : 1129 - 1129
  • [26] DRUG SURVIVAL OF SECOND BIOLOGIC DMARD THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS: COMPARISON OF A SECOND ANTI-TUMOUR NECROSIS FACTOR WITH A SECOND NON-ANTI-TUMOUR NECROSIS FACTOR AFTER DISCONTINUATION OF A FIRST ANTI-TUMOUR NECROSIS FACTOR
    Wilke, Thomas
    Mueller, Sabrina
    Majer, Istvan
    Heisen, Marieke
    Fuchs, Andreas
    Maywald, Ulf
    RHEUMATOLOGY, 2016, 55 : 105 - 105
  • [27] Reporting the response to anti-tumour necrosis factor treatment
    Volc, S.
    Ghoreschi, K.
    BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 (05) : 867 - 868
  • [28] ANKYLOSING SPONDYLITIS: ANTI-TUMOUR NECROSIS FACTOR AND BEYOND
    Sengupta, Raj
    RHEUMATOLOGY, 2017, 56 : 10 - 10
  • [29] Digital vasculitis: a late complication of anti-tumour necrosis factor alpha therapy
    Mangat, Pamela
    Whittle, Samuel
    Cleland, Les
    Limaye, Vidya
    CLINICAL RHEUMATOLOGY, 2008, 27 (12) : 1593 - 1595
  • [30] Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-α therapy
    Rosner, I.
    Haddad, A.
    Boulman, N.
    Feld, J.
    Avshovich, N.
    Slobodin, G.
    Rozenbaum, M.
    RHEUMATOLOGY, 2007, 46 (09) : 1508 - 1508